We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$136M
AUM Growth
-$24.9M
Cap. Flow
-$96M
Cap. Flow %
-70.53%
Top 10 Hldgs %
51.55%
Holding
51
New
11
Increased
1
Reduced
–
Closed
11

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$8.91M
2
OPOF
Old Point Financial
OPOF
+$7.18M
3
BPMC
Blueprint Medicines
BPMC
+$6.23M
4
VIGL
Vigil Neuroscience
VIGL
+$2.16M
5
PWOD
Penns Woods Bancorp
PWOD
+$1.8M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$11.9M
2
FNA
Paragon 28, Inc.
FNA
+$7.46M
3
CCRN
Cross Country Healthcare
CCRN
+$5.99M
4
PDCO
Patterson Companies, Inc.
PDCO
+$4.92M
5
EVBN
Evans Bancorp Inc
EVBN
+$4.44M

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Financials 8.9%
3 Industrials 2.98%
4 Energy 0.51%
5 Technology 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBMS
26
DELISTED
The First Bancshares, Inc.
FBMS
– –
-10,543
Closed -$357K
1
2

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
GW
Graetz Wealth Jenison, Michigan $112M AUM
TBNY
Trustco Bank (New York) Albany, New York $113M AUM 34.59% 1-Year Est. Return

Chicago Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Chicago Capital Management held 51 positions worth $136M, down 15% from $161M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Chicago Capital Management withdrew a net $96M in Q2 2025, closing 11 positions. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chicago Capital Management opened a new position in SpringWorks Therapeutics worth $9.41M.

  • Chicago Capital Management's largest Q2 2025 buy was SpringWorks Therapeutics: 200,230 shares worth $9.41M.
  • Chicago Capital Management added most to Penns Woods Bancorp in Q2 2025, an estimated $1.8M increase.
  • Chicago Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $11.9M.
  • Chicago Capital Management's ten largest holdings make up 52% of its $136M portfolio in Q2 2025.
  • Chicago Capital Management opened 11 new positions and closed 11 in Q2 2025.
  • Chicago Capital Management's portfolio value fell 15% quarter-over-quarter to $136M.

Based on Chicago Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.